Goodwin Procter advised Ducentis BioTherapeutics on the deal. Ducentis BioTherapeutics announced its acquisition by Arcutis Biotherapeutics for up to $400 million. Ducentis BioTherapeutics, a portfolio company of...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell, Mayer Brown, and Mishcon de Reya advised Gilead, while Goodwin Procter and Wilson Sonsini Goodrich & Rosati advised MiroBio on the deal....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Workspace Group PLC on the deal. Workspace Group PLC announced the sale of the freehold interest in 13-17 Fitzroy Street, London to DWS for...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Exscientia on the deal while Goodwin Procter represented Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, BofA Securities and Barclays Capital...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Omega Funds on the deal. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company exploiting a broad DDR-based platform and small...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Rare Whisky Holdings on the deal. Rare Whisky Holdings announced its agreement to acquire a 49% stake in Whisky Hammer and Still Spirit. Rare...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP, working alongside Carey Olsen, advised Clarion Partners Europe on the deal while Greenberg Trauri represented Dream Industrial REIT. Clarion Partners Europe announced the sale...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Goodwin Procter LLP advised Centessa Pharmaceuticals on the deal. Centessa Pharmaceuticals, a clinical-stage company employing its innovative asset-centric business model...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised COMPASS Pathways plc on the deal. COMPASS Pathways plc (Nasdaq: CMPS) announced its public follow-on offering of 4,000,000 American Depositary Shares (“ADSs”) representing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised COMPASS Pathways plc on the deal. COMPASS Pathways plc (Nasdaq: CMPS) announced its public follow-on offering of 4,000,000 American Depositary Shares (“ADSs”) representing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Behrman Capital on the deal. Behrman Capital announced the completion of its bolt-on acquisition of contract research organization Orphan Reach via its portfolio...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Levine Leichtman Capital Partners on the deal. Levine Leichtman Capital Partners announced its investment in Prime Global Medical Communications Ltd. in partnership with...
You must be a Standard 1 Year member to access this content.
